Close Menu

Churning Out Some LSD

Jake Wintermute at Harvard University is on his way to using synthetic biology to make lysergic acid, a precursor to LSD, reports Ian Sample at the Guardian. Lysergic acid is also used to make certain medications. Wintermute gave an update on his work at the Synthetic Biology 5 meeting at Stanford University, and said that though he is not yet making lysergic acid, he has inserted two of the six needed biochemical pathways into yeast.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.